Stocks are at or near all-time highs as investors turn the page to December, and as far as investors are concerned, there appears to be no reason why they can’t go higher still.
Category: Uncategorized
Buy the equal-weighted S&P 500 ETF and short Cathie Wood’s Ark Innovation, Trivariate Research says
Trivariate Research says this pair trade offers a way to capitalize on postelection optimism heading into 2025.
UBS names its top retail stock picks this holiday shopping season
Research shows consumers want to spend this holiday season. These are the so-called ‘softline’ retail names on the UBS buy list.
JPMorgan’s top biotech stock picks for 2025 as sector looks for a comeback year
While 2024 marked another “challenging” year for biotech stocks, some names could be slated for upside in the months ahead, according to JPMorgan.
These ETFs could be a more cautious way to bet on a stock market rally in 2025
Astoria Portfolio Advisors unveiled its top ETF picks for the coming year.
Stocks to give thanks for this year after big gains. And what to do with them now
Analysts’ consensus price targets suggest meager gains or worse are in store for some of the S&P 500’s top-performing stocks this year.
These economists say artificial intelligence can narrow U.S. deficits by improving health care
Economists at the Brookings Institution estimate AI could reduce the U.S. budget deficit some $900 billion by 2044.
Financials are the best performing stocks of 2024. Here’s one corner that could do especially well
Fintech stocks are poised to outpace a financial sector that’s expected to benefit from a second Trump administration.
The Magnificent Seven ETF is teetering. What the charts say will happen next
Frank Cappelleri breaks down the charts on the Roundhill Magnificent Seven ETF.
Trump wants to cut corporate taxes to as low as 15%. These stocks could benefit the most, Wolfe says
The firm screened for names that could see a boost to their earnings if corporate taxes come down to 15%.